Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers
TA Couttas, C Boost, F Pahlisch… - BMJ Ment …, 2024 - mentalhealth.bmj.com
Background The mental health benefits of cannabidiol (CBD) are promising but can be
inconsistent, in part due to challenges in defining an individual's effective dosage. In …
inconsistent, in part due to challenges in defining an individual's effective dosage. In …
Endocannabinoid levels in plasma and neurotransmitters in the brain: a preliminary report on patients with a psychotic disorder and healthy individuals
CFM van Hooijdonk, MGJ Balvers… - Psychological …, 2024 - cambridge.org
BackgroundInteractions between the endocannabinoid system (ECS) and neurotransmitter
systems might mediate the risk of developing a schizophrenia spectrum disorder (SSD) …
systems might mediate the risk of developing a schizophrenia spectrum disorder (SSD) …
Absence of Evidence for Sustained Effects of Daily Cannabidiol Administration on Anandamide Plasma Concentration in Individuals with Cocaine Use Disorder …
FO Hebert, V Mongeau-Pérusse… - Cannabis and …, 2024 - liebertpub.com
Background: Cannabidiol (CBD) has been proposed to have a therapeutic potential over a
wide range of neuropsychiatric disorders, including substance use disorders. Pre-clinical …
wide range of neuropsychiatric disorders, including substance use disorders. Pre-clinical …
Exploring Chemovar-Specific Cannabis Extracts Quantification and Evaluation of Cytotoxic Compounds for Targeting Glioblastoma Multiforme
A Duzan, M Basti, T Cesarone… - … of Biosciences and …, 2023 - nsuworks.nova.edu
Glioblastoma Multiforme (GBM) represents one of the most aggressive and metastatic brain
tumors, with a dismal success rate of less than three percent after five years, particularly in …
tumors, with a dismal success rate of less than three percent after five years, particularly in …